View More View Less
  • 1 Debreceni Egyetem, Orvos- és Egészségtudományi Centrum Kardiológiai Intézet Debrecen Móricz Zs. krt. 22. 4032
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

A diasztolés szívelégtelenség, amelyet megőrzött ejekciós frakciójú szívelégtelenségnek is neveznek, egy olyan klinikai szindróma, amelyben a szívelégtelenségre jellemző tünetek és panaszok normális vagy közel normális bal kamrai ejekciós frakció (≥50%) és a diasztolés diszfunkció objektív jelei mellett észlelhetőek. Az újabb epidemiológiai vizsgálatok igazolták, hogy a szívelégtelenségben szenvedő betegek több mint felénél diasztolés szívelégtelenség áll fenn. A betegség, amelynek prevalenciája az életkorral növekszik, gyakoribb nőkben, mint férfiakban. A diasztolés szívelégtelenségben szenvedő betegek egy nagyon heterogén csoportot alkotnak, összetett kórélettani mechanizmusokkal. A betegség gyakran társul más betegségekkel, mint például magas vérnyomással, diabetes mellitussal vagy obesitassal. A diasztolés szívelégtelenség diagnosztizálására alkalmazott legjobb módszer a kétdimenziós, valamint a Doppler-echokardiográfia, amellyel detektálható a rendellenes myocardialis relaxáció, a csökkent bal kamrai tágulékonyság és a megnövekedett bal kamrai töltőnyomás normális bal kamrai dimenziók és ejekciós frakció mellett. A csökkent ejekciós frakciójú szívelégtelenséggel ellentétben a megőrzött ejekciós frakciójú szívelégtelenség kezelésére nem áll rendelkezésre olyan bizonyítékokon alapuló terápia, amely a klinikai kimenetelt javítaná. A diasztolés szívelégtelenség gyógyszeres kezelése így legfőképpen az empirikus tapasztalatokon alapszik, és a vérnyomás normalizálására, a balkamra-hypertrophia regressziójának elősegítésére, a tachycardia megelőzésére, a normális pitvari kontrakció fenntartására és a pangásos tünetek csökkentésére irányul. Ennek során kihasználható az angiotenzinkonvertálóenzim-gátlók és az angiotenzinreceptor-blokkolók vélhetően kedvező hatása a diasztolés diszfunkcióra nézve, különösen magas vérnyomásos betegekben. A béta-blokkolók a gyors szívfrekvencia kivédésére és a bal kamrai diasztolés telődési idő megnyújtására, míg a vízhajtó gyógyszerek a pulmonalis pangás kezelésére alkalmasak. Mindemellett fontos a háttérben meghúzódó alapbetegségek kezelése is a diasztolés szívelégtelenség terápiájában. Jelen közlemény a mai tudásunk alapján összegzi a diasztolés szívelégtelenségre vonatkozó ismereteket. Orv. Hetil., 2012, 153, 2030–2040.

  • Fishberg, A. M.: Heart failure. Lea & Febiger, Philadelphia, 1937.

    Fishberg A. M. , '', in Heart failure , (1937 ) -.

  • Owan, T. E., Hodge, D. O., Herges, R. M., et al.: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med., 2006, 355, 251–259.

    Herges R. M. , 'Trends in prevalence and outcome of heart failure with preserved ejection fraction ' (2006 ) 355 N. Engl. J. Med. : 251 -259.

    • Search Google Scholar
  • Hogg, K., Swedberg, K., McMurray, J.: Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J. Am. Coll. Cardiol., 2004, 43, 317–327.

    McMurray J. , 'Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis ' (2004 ) 43 J. Am. Coll. Cardiol. : 317 -327.

    • Search Google Scholar
  • McManus, D. D., Xanthakis, V., Sullivan, L. M., et al.: Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community. Circulation, 2010, 121, 667–674.

    Sullivan L. M. , 'Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community ' (2010 ) 121 Circulation : 667 -674.

    • Search Google Scholar
  • Takeda, Y., Sakata, Y., Mano, T., et al.: Competing risks of heart failure with preserved ejection fraction in diabetic patients. Eur. J. Heart Fail., 2011, 13, 664–669.

    Mano T. , 'Competing risks of heart failure with preserved ejection fraction in diabetic patients ' (2011 ) 13 Eur. J. Heart Fail. : 664 -669.

    • Search Google Scholar
  • Bhatia, R. S., Tu, J. V., Lee, D. S., et al.: Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med., 2006, 355, 260–269.

    Lee D. S. , 'Outcome of heart failure with preserved ejection fraction in a population-based study ' (2006 ) 355 N. Engl. J. Med. : 260 -269.

    • Search Google Scholar
  • Philbin, E. F., Rocco, T. A. jr., Lindenmuth, N. W., et al.: Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am. J. Med., 2000, 109, 605–613.

    Lindenmuth N. W. , 'Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors ' (2000 ) 109 Am. J. Med. : 605 -613.

    • Search Google Scholar
  • Zile, M. R., Brutsaert, D. L.: New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation, 2002, 105, 1387–1393.

    Brutsaert D. L. , 'New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function ' (2002 ) 105 Circulation : 1387 -1393.

    • Search Google Scholar
  • Zile, M. R., Baicu, C. F., Gaasch, W. H.: Diastolic heart failure – abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med., 2004, 350, 1953–1959.

    Gaasch W. H. , 'Diastolic heart failure – abnormalities in active relaxation and passive stiffness of the left ventricle ' (2004 ) 350 N. Engl. J. Med. : 1953 -1959.

    • Search Google Scholar
  • Westermann, D., Kasner, M., Steendijk, P., et al.: Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation, 2008, 117, 2051–2060.

    Steendijk P. , 'Role of left ventricular stiffness in heart failure with normal ejection fraction ' (2008 ) 117 Circulation : 2051 -2060.

    • Search Google Scholar
  • Bhuiyan, T., Helmke, S., Patel, A. R., et al.: Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS). Circ. Heart Fail., 2011, 4, 121–128.

    Patel A. R. , 'Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS) ' (2011 ) 4 Circ. Heart Fail. : 121 -128.

    • Search Google Scholar
  • Maurer, M. S., Burkhoff, D., Fried, L. P., et al.: Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J. Am. Coll. Cardiol., 2007, 49, 972–981.

    Fried L. P. , 'Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study ' (2007 ) 49 J. Am. Coll. Cardiol. : 972 -981.

    • Search Google Scholar
  • Abramov, D., He, K. L., Wang, J., et al.: The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction. J. Card. Fail., 2011, 17, 547–555.

    Wang J. , 'The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction ' (2011 ) 17 J. Card. Fail. : 547 -555.

    • Search Google Scholar
  • Kitzman, D. W., Higginbotham, M. B., Cobb, F. R., et al.: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J. Am. Coll. Cardiol., 1991, 17, 1065–1072.

    Cobb F. R. , 'Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism ' (1991 ) 17 J. Am. Coll. Cardiol. : 1065 -1072.

    • Search Google Scholar
  • Borlaug, B. A., Lam, C. S., Roger, V. L., et al.: Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J. Am. Coll. Cardiol., 2009, 54, 410–418.

    Roger V. L. , 'Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction ' (2009 ) 54 J. Am. Coll. Cardiol. : 410 -418.

    • Search Google Scholar
  • Borlaug, B. A., Melenovsky, V., Russell, S. D., et al.: Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation, 2006, 114, 2138–2147.

    Russell S. D. , 'Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction ' (2006 ) 114 Circulation : 2138 -2147.

    • Search Google Scholar
  • Ennezat, P. V., Lefetz, Y., Marechaux, S., et al.: Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J. Card. Fail., 2008, 14, 475–480.

    Marechaux S. , 'Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest ' (2008 ) 14 J. Card. Fail. : 475 -480.

    • Search Google Scholar
  • Borlaug, B. A., Olson, T. P., Lam, C. S., et al.: Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol., 2010, 56, 845–854.

    Lam C. S. , 'Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction ' (2010 ) 56 J. Am. Coll. Cardiol. : 845 -854.

    • Search Google Scholar
  • Borbely, A., van der Velden, J., Papp, Z., et al.: Cardiomyocyte stiffness in diastolic heart failure. Circulation, 2005, 111, 774–781.

    Papp Z. , 'Cardiomyocyte stiffness in diastolic heart failure ' (2005 ) 111 Circulation : 774 -781.

    • Search Google Scholar
  • Borbely, A., Falcao-Pires, I., van Heerebeek, L., et al.: Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ. Res., 2009, 104, 780–786.

    Heerebeek L. , 'Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium ' (2009 ) 104 Circ. Res. : 780 -786.

    • Search Google Scholar
  • Kruger, M., Kotter, S., Grutzner, A., et al.: Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ. Res., 2009, 104, 87–94.

    Grutzner A. , 'Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs ' (2009 ) 104 Circ. Res. : 87 -94.

    • Search Google Scholar
  • Lopez, B., Querejeta, R., Gonzalez, A., et al.: Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. Hypertension, 2009, 53, 236–242.

    Gonzalez A. , 'Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure ' (2009 ) 53 Hypertension : 236 -242.

    • Search Google Scholar
  • Gonzalez, A., Ravassa, S., Beaumont, J., et al.: New targets to treat the structural remodeling of the myocardium. J. Am. Coll. Cardiol., 2011, 58, 1833–1843.

    Beaumont J. , 'New targets to treat the structural remodeling of the myocardium ' (2011 ) 58 J. Am. Coll. Cardiol. : 1833 -1843.

    • Search Google Scholar
  • Brilla, C. G., Funck, R. C., Rupp, H.: Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation, 2000, 102, 1388–1393.

    Rupp H. , 'Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease ' (2000 ) 102 Circulation : 1388 -1393.

    • Search Google Scholar
  • Diez, J., Querejeta, R., Lopez, B., et al.: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation, 2002, 105, 2512–2517.

    Lopez B. , 'Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients ' (2002 ) 105 Circulation : 2512 -2517.

    • Search Google Scholar
  • Kobayashi, M., Machida, N., Mitsuishi, M., et al.: Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Am. J. Hypertens., 2004, 17 (12Pt 1), 1112–1119.

    Mitsuishi M. , 'Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure ' (2004 ) 17 Am. J. Hypertens. : 1112 -1119.

    • Search Google Scholar
  • Lopez, B., Querejeta, R., Gonzalez, A., et al.: Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J. Am. Coll. Cardiol., 2004, 43, 2028–2035.

    Gonzalez A. , 'Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure ' (2004 ) 43 J. Am. Coll. Cardiol. : 2028 -2035.

    • Search Google Scholar
  • Varo, N., Etayo, J. C., Zalba, G., et al.: Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J. Hypertens., 1999, 17, 107–114.

    Zalba G. , 'Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats ' (1999 ) 17 J. Hypertens. : 107 -114.

    • Search Google Scholar
  • Veeraveedu, P. T., Watanabe, K., Ma, M., et al.: Comparative effects of torasemide and furosemide in rats with heart failure. Biochem. Pharmacol., 2008, 75, 649–659.

    Ma M. , 'Comparative effects of torasemide and furosemide in rats with heart failure ' (2008 ) 75 Biochem. Pharmacol. : 649 -659.

    • Search Google Scholar
  • Yamada, T., Fukunami, M., Ohmori, M., et al.: Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint. J. Am. Coll. Cardiol., 1993, 21, 628–633.

    Ohmori M. , 'Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint ' (1993 ) 21 J. Am. Coll. Cardiol. : 628 -633.

    • Search Google Scholar
  • Zannad, F., Radauceanu, A.: Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure. Heart Fail. Rev., 2005, 10, 71–78.

    Radauceanu A. , 'Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure ' (2005 ) 10 Heart Fail. Rev. : 71 -78.

    • Search Google Scholar
  • Chlopicki, S., Gryglewski, R. J.: Angiotensin converting enzyme (ACE) and hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium. Pharmacol. Rep., 2005, 57 (Suppl.), 86–96.

    Gryglewski R. J. , 'Angiotensin converting enzyme (ACE) and hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium ' (2005 ) 57 Pharmacol. Rep. : 86 -96.

    • Search Google Scholar
  • Van Heerebeek, L., Hamdani, N., Falcao-Pires, I., et al.: Low myocardial protein kinase g activity in heart failure with preserved ejection fraction. Circulation, 2012, 126, 830–839.

    Falcao-Pires I. , 'Low myocardial protein kinase g activity in heart failure with preserved ejection fraction ' (2012 ) 126 Circulation : 830 -839.

    • Search Google Scholar
  • Hartge, M. M., Unger, T., Kintscher, U.: The endothelium and vascular inflammation in diabetes. Diabetes Vasc. Dis. Res., 2007, 4, 84–88.

    Kintscher U. , 'The endothelium and vascular inflammation in diabetes ' (2007 ) 4 Diabetes Vasc. Dis. Res. : 84 -88.

    • Search Google Scholar
  • Czuriga, D., Paulus, W. J., Czuriga, I., et al.: Cellular mechanisms for diastolic dysfunction in the human heart. Curr. Pharm. Biotechnol., 2012 Jan 20. [Epub ahead of print] Epub: http://www.ncbi.nlm.nih.gov/pubmed/22280428

  • Paulus, W. J., Tschope, C., Sanderson, J. E., et al.: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J., 2007, 28, 2539–2550.

    Sanderson J. E. , 'How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology ' (2007 ) 28 Eur. Heart J. : 2539 -2550.

    • Search Google Scholar
  • Stoddard, M. F., Pearson, A. C., Kern, M. J., et al.: Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans. Circulation, 1989, 79, 1226–1236.

    Kern M. J. , 'Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans ' (1989 ) 79 Circulation : 1226 -1236.

    • Search Google Scholar
  • Czuriga, I.: Heart failure. Clinical evidence. [Szívelégtelenség. Klinikai bizonyítékok.] Medicina Könyvkiadó, Budapest, 2006. [Hungarian]

    Czuriga I. , '', in Heart failure. Clinical evidence. [Szívelégtelenség. Klinikai bizonyítékok.] , (2006 ) -.

    • Search Google Scholar
  • Paulus, W. J., van Ballegoij, J. J.: Treatment of heart failure with normal ejection fraction: an inconvenient truth!. J. Am. Coll. Cardiol., 2010, 55, 526–537.

    Ballegoij J. J. , 'Treatment of heart failure with normal ejection fraction: an inconvenient truth! ' (2010 ) 55 J. Am. Coll. Cardiol. : 526 -537.

    • Search Google Scholar
  • Yip, G. W., Wang, M., Wang, T., et al.: The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart, 2008, 94, 573–580.

    Wang T. , 'The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction ' (2008 ) 94 Heart : 573 -580.

    • Search Google Scholar
  • Beckett, N. S., Peters, R., Fletcher, A. E., et al.: Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med., 2008, 358, 1887–1898.

    Fletcher A. E. , 'Treatment of hypertension in patients 80 years of age or older ' (2008 ) 358 N. Engl. J. Med. : 1887 -1898.

    • Search Google Scholar
  • Cleland, J. G., Tendera, M., Adamus, J., et al.: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur. Heart J., 2006, 27, 2338–2345.

    Adamus J. , 'The perindopril in elderly people with chronic heart failure (PEP-CHF) study ' (2006 ) 27 Eur. Heart J. : 2338 -2345.

    • Search Google Scholar
  • Fu, M., Zhou, J., Sun, A., et al.: Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction – a meta analysis of 7 prospective clinical studies. Int. J. Cardiol., 2012, 155, 33–38.

    Sun A. , 'Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction – a meta analysis of 7 prospective clinical studies ' (2012 ) 155 Int. J. Cardiol. : 33 -38.

    • Search Google Scholar
  • Wachtell, K., Bella, J. N., Rokkedal, J., et al.: Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation, 2002, 105, 1071–1076.

    Rokkedal J. , 'Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study ' (2002 ) 105 Circulation : 1071 -1076.

    • Search Google Scholar
  • Yusuf, S., Pfeffer, M. A., Swedberg, K., et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet, 2003, 362, 777–781.

    Swedberg K. , 'Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial ' (2003 ) 362 Lancet : 777 -781.

    • Search Google Scholar
  • Massie, B. M., Carson, P. E., McMurray, J. J., et al.: Irbesartan in patients with heart failure and preserved ejection fraction. N. Engl. J. Med., 2008, 359, 2456–2467.

    McMurray J. J. , 'Irbesartan in patients with heart failure and preserved ejection fraction ' (2008 ) 359 N. Engl. J. Med. : 2456 -2467.

    • Search Google Scholar
  • Aronow, W. S., Ahn, C., Kronzon, I.: Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am. J. Cardiol., 1997, 80, 207–209.

    Kronzon I. , 'Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors ' (1997 ) 80 Am. J. Cardiol. : 207 -209.

    • Search Google Scholar
  • Dobre, D., van Veldhuisen, D. J., DeJongste, M. J., et al.: Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival. Eur. J. Heart Fail., 2007, 9, 280–286.

    DeJongste M. J. , 'Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival ' (2007 ) 9 Eur. J. Heart Fail. : 280 -286.

    • Search Google Scholar
  • Massie, B. M., Nelson, J. J., Lukas, M. A., et al.: Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. Am. J. Cardiol., 2007, 99, 1263–1268.

    Lukas M. A. , 'Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice ' (2007 ) 99 Am. J. Cardiol. : 1263 -1268.

    • Search Google Scholar
  • Bergstrom, A., Andersson, B., Edner, M., et al.: Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish doppler-echocardiographic study (SWEDIC). Eur. J. Heart Fail., 2004, 6, 453–461.

    Edner M. , 'Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish doppler-echocardiographic study (SWEDIC) ' (2004 ) 6 Eur. J. Heart Fail. : 453 -461.

    • Search Google Scholar
  • Flather, M. D., Shibata, M. C., Coats, A. J., et al.: Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J., 2005, 26, 215–225.

    Coats A. J. , 'Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) ' (2005 ) 26 Eur. Heart J. : 215 -225.

    • Search Google Scholar
  • Ghio, S., Magrini, G., Serio, A., et al.: Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. Eur. Heart J., 2006, 27, 562–568.

    Serio A. , 'Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy ' (2006 ) 27 Eur. Heart J. : 562 -568.

    • Search Google Scholar
  • Mottram, P. M., Haluska, B., Leano, R., et al.: Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation, 2004, 110, 558–565.

    Leano R. , 'Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure ' (2004 ) 110 Circulation : 558 -565.

    • Search Google Scholar
  • Pieske, B.: The aldosterone receptor blockade in diastolic heart failure (ALDO-DHF). Presented at the ESC meeting in Munich, Germany, 27 Aug 2012.

  • Ahmed, A., Rich, M. W., Fleg, J. L., et al.: Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation, 2006, 114, 397–403.

    Fleg J. L. , 'Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial ' (2006 ) 114 Circulation : 397 -403.

    • Search Google Scholar
  • Fukuta, H., Sane, D. C., Brucks, S., et al.: Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation, 2005, 112, 357–363.

    Brucks S. , 'Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report ' (2005 ) 112 Circulation : 357 -363.

    • Search Google Scholar
  • Guazzi, M., Vicenzi, M., Arena, R., et al.: Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation, 2011, 124, 164–174.

    Arena R. , 'Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study ' (2011 ) 124 Circulation : 164 -174.

    • Search Google Scholar
  • Redfield, M. M., Borlaug, B. A., Lewis, G. D., et al.: PhosphodiesteRasE-5 inhibition to Improve clinical status and exercise capacity in diastolic heart failure (RELAX) Trial: Rationale and Design. Circ. Heart Fail., 2012, 5, 653–659.

    Lewis G. D. , 'PhosphodiesteRasE-5 inhibition to Improve clinical status and exercise capacity in diastolic heart failure (RELAX) Trial: Rationale and Design ' (2012 ) 5 Circ. Heart Fail. : 653 -659.

    • Search Google Scholar